| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | PNT | Common Stock | Award | +35.9K | 35.9K | Jun 30, 2021 | Long Zone Holdings Inc. | F1, F2, F3 |
| Id | Content |
|---|---|
| F1 | On June 30, 2021, POINT BIOPHARMA GLOBAL INC. (f/k/a Therapeutics Acquisition Corp., the "Issuer") consummated a business combination (the "Business Combination") pursuant to which Bodhi Merger Sub, Inc., a wholly-owned subsidiary of the Issuer, merged with and into POINT Biopharma Inc. ("Old POINT"). At the effective time of the Business Combination, each share of Old POINT outstanding as of immediately prior to the effective time was exchanged for shares of Common Stock of the Issuer based on an implied Old POINT vested equity value of $585,000,000. As a result, the Reporting Person received the reported shares of the Issuer's Common Stock in consideration for the equity securities of Old POINT held by the Reporting Person prior to the Business Combination. |
| F2 | This amendment is being filed to correct an administrative error in a Form 4 filed by the Reporting Person on June 30, 2021, which incorrectly reported 21,523 shares of Common Stock as beneficially owned by the Reporting Person directly. This amendment reflects the correct number of shares of Common Stock beneficially owned by the Reporting Person as of June 30, 2021. |
| F3 | A corporation controlled by Reporting Person |